19.10.2020 • NewsBrenntag

Brenntag Buys Italy’s Comelt

Brenntag has agreed to buy Italian activated carbon company Comelt and its subsidiary Aquadepur for an undisclosed sum.

Comelt processes, markets and distributes activated and re-activated carbon for uses that include filtering water and purifying air and flue gas. The business generated sales of approximately €31 million in the financial year 2019.

The acquisition includes warehouses and a laboratory in northern Italy. The warehouses are located in Cernusco sul Naviglio, Milan; Cairo Montenotte, Savona; and Casirate d’Adda, Bergamo. Comelt also owns an activated carbon washing plant as well as a carbon reactivation facility.

“We expect an increasing demand for activated carbon for years to come due to the stricter purity standards for air and water quality,” said Brenntag Group managing director, mergers & acquisitions, Anthony Gerace. “The acquisition of Comelt will strengthen our ability to assist our customers with meeting their sustainability objectives. This is an opportunity for Brenntag to increase our market share in these important high growth and significant market segments in Italy as well as in other European countries.”

The transaction is expected to close in the final quarter of 2020, subject to the usual conditions and regulatory approvals.

Author: Elaine Burridge, Freelance Journalist

 

Foto: Brenntag
Foto: Brenntag

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Netherlands

Company contact







Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.